share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Officer Vittiglio Joseph

bluebird bio | 4:持股變動聲明-高管 Vittiglio Joseph

SEC announcement ·  02/07 05:13
牛牛AI助理已提取核心訊息
Joseph Vittiglio, the Chief Business & Legal Officer of bluebird bio, Inc., completed a sale of 5,217 shares of common stock on February 5, 2024. The transaction was carried out on the open market with the shares sold at a price of $0.9025 each, resulting in a total sale value of $4,708.34. Following the sale, Vittiglio's direct holdings in the company amount to 44,783 shares of common stock.
Joseph Vittiglio, the Chief Business & Legal Officer of bluebird bio, Inc., completed a sale of 5,217 shares of common stock on February 5, 2024. The transaction was carried out on the open market with the shares sold at a price of $0.9025 each, resulting in a total sale value of $4,708.34. Following the sale, Vittiglio's direct holdings in the company amount to 44,783 shares of common stock.
藍鳥生物公司首席商務與法律官約瑟夫·維蒂格里奧於2024年2月5日完成了5,217股普通股的出售。該交易在公開市場上進行,股票以每股0.9025美元的價格出售,總銷售價值爲4,708.34美元。出售後,維蒂格里奧在該公司的直接持有量爲44,783股普通股。
藍鳥生物公司首席商務與法律官約瑟夫·維蒂格里奧於2024年2月5日完成了5,217股普通股的出售。該交易在公開市場上進行,股票以每股0.9025美元的價格出售,總銷售價值爲4,708.34美元。出售後,維蒂格里奧在該公司的直接持有量爲44,783股普通股。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。